- Home
- HOOK vs AEON Comparison
HOOK vs AEON Comparison
Compare HOOK & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- AEON
- Stock Information
- Founded
- HOOK 2011
- AEON N/A
- Country
- HOOK United States
- AEON United States
- Employees
- HOOK N/A
- AEON N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- HOOK Health Care
- AEON Health Care
- Exchange
- HOOK Nasdaq
- AEON Nasdaq
- Market Cap
- HOOK 24.5M
- AEON 21.6M
- IPO Year
- HOOK 2019
- AEON N/A
- Fundamental
- Price
- HOOK $1.99
- AEON $0.12
- Analyst Decision
- HOOK Buy
- AEON Strong Buy
- Analyst Count
- HOOK 4
- AEON 1
- Target Price
- HOOK $10.67
- AEON $5.00
- AVG Volume (30 Days)
- HOOK 266.1K
- AEON 46.5M
- Earning Date
- HOOK 03-21-2025
- AEON 11-13-2024
- Dividend Yield
- HOOK N/A
- AEON N/A
- EPS Growth
- HOOK N/A
- AEON N/A
- EPS
- HOOK N/A
- AEON 0.34
- Revenue
- HOOK $49,999,000.00
- AEON N/A
- Revenue This Year
- HOOK $148.80
- AEON N/A
- Revenue Next Year
- HOOK N/A
- AEON N/A
- P/E Ratio
- HOOK N/A
- AEON $0.35
- Revenue Growth
- HOOK 143.30
- AEON N/A
- 52 Week Low
- HOOK $1.72
- AEON $0.10
- 52 Week High
- HOOK $10.50
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- HOOK 45.83
- AEON 26.21
- Support Level
- HOOK $1.80
- AEON $0.10
- Resistance Level
- HOOK $1.99
- AEON $0.22
- Average True Range (ATR)
- HOOK 0.24
- AEON 0.04
- MACD
- HOOK 0.05
- AEON -0.01
- Stochastic Oscillator
- HOOK 25.35
- AEON 4.83
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.